Bénéfice Avant Impôts Changement Date
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
Arrowhead Research USD -178.9M 41.34M 2026-06
Astellas Pharma JPY 186.51B 138.49B 2026-06
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Celltrion KRW 11.84B 1.34B 2026-03
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Divis Laboratories Ltd INR 11.8B 2.17B 2026-06
Exelixis USD 262.68M 5.01M 2026-06
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Ionis Pharmaceuticals USD -114M 21M 2026-06
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Moderna USD -1.33B 535M 2026-03
Nektar Therapeutics USD -43.09M 8.39M 2026-03
Neuren Pharmaceuticals AUD 19.21M 9.35M 2025-12
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 4.27B 430M 2026-06
Omeros USD -65.12M 21.27M 2024-06
OPKO Health USD -60.96M 14.06M 2026-03
Organigram Holdings CAD -921K 40.8M 2026-03
Pfizer USD -653M 5.84B 2026-06
Pharma Mar EUR -993K 2.59M 2026-06
PTC Therapeutics USD -2.46M 136.62M 2026-03
Qiagen NV USD 157.9M 72.08M 2026-06
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Sartorius EUR 127M 30.8M 2026-06
Tilray USD -39.96M 39.19M 2025-09
Ultragenyx Pharmaceutical USD -91M 93M 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06
Zealand Pharma A/S -394M 12.5M 2026-03
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03